Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munsat, T. L.
Right arrow Articles by Thibodeau, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munsat, T. L.
Right arrow Articles by Thibodeau, L.
NEUROLOGY 1988;38:409
© 1988 American Academy of Neurology

The natural history of motoneuron loss in amyotrophic lateral sclerosis

T. L. Munsat, MD, P. L. Andres, MS, RPT, L. Finison, PhD, T. Conlon, MPH and L. Thibodeau, PTA

From the Neuromuscular Research Unit, Department of Neurology, New England Medical Center, Boston, MA.

Using a quantitative, reliable, sensitive and valid measurement technique, we analyzed the rate and pattern of motor deterioration in 50 strictly defined ALS patients for up to 67 months. We observed that the rate of motoneuron loss was linear and symmetric. Bulbar function deteriorated more slowly than respiratory, arm, and leg function. The loss of leg strength was slower than in the arm. No correlation was observed between age at onset and rate of deterioration, or with different regions of onset. Arm strength changed more slowly in women, but other functions showed no male-female differences. These data should prove useful in the design of clinical trials and in generating testable hypotheses of the etiology of this disease.

Address correspondence and reprint requests to Dr. Munsat, New England Medical Center, 750 Washington Street, Box 273, Boston, MA 02111.

Supported by NIH grants GCRC #M01RR00054 and R01NS24623 and a grant from the Muscular Dystrophy Association.

Received January 30, 1987. Accepted for publication in final form June 26, 1987.




This article has been cited by other articles:


Home page
NeurologyHome page
J. M. Ravits and A. R. La Spada
ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
Neurology, September 8, 2009; 73(10): 805 - 811.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. H. Gordon, P. Corcia, L. Lacomblez, K. Pochigaeva, J.-L. Abitbol, M. Cudkowicz, P. N. Leigh, and V. Meininger
Defining Survival as an Outcome Measure in Amyotrophic Lateral Sclerosis
Arch Neurol, June 1, 2009; 66(6): 758 - 761.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. R. Mills
The natural history of central motor abnormalities in amyotrophic lateral sclerosis
Brain, November 1, 2003; 126(11): 2558 - 2566.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. T. Iannaccone and L. S. Hynan
Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy
Arch Neurol, August 1, 2003; 60(8): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M.A. del Aguila, W.T. Longstreth Jr, V. McGuire, T.D. Koepsell, and G. van Belle
Prognosis in amyotrophic lateral sclerosis: A population-based study
Neurology, March 11, 2003; 60(5): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Turner, A. Al-Chalabi, A. Chio, and G. Mora
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Neurology, December 24, 2002; 59(12): 2012 - 2013.
[Full Text] [PDF]


Home page
NeurologyHome page
Randomized pilot trial of {beta}INF1a (Avonex) in patients with inclusion body myositis
Neurology, November 13, 2001; 57(9): 1566 - 1570.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. F. Ansevin
Treatment of ALS with pleconaril
Neurology, March 13, 2001; 56(5): 691 - 695.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. W. Bryan, J. S. Reisch, G. McDonald, L. L. Herbelin, R. J. Barohn, and J. L. Fleckenstein
Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis
Neurology, July 1, 1998; 51(1): 110 - 113.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
A. Worthington
Psychological aspects of motor neurone disease: a review
Clinical Rehabilitation, August 1, 1996; 10(3): 185 - 194.
[PDF]


Home page
Palliat MedHome page
E. A. Oppenheimer
Decision-making in the respiratory care of amyotrophic lateral sclerosis: should home mechanical ventilation be used?
Palliative Medicine, October 1, 1993; 7(4_suppl): 49 - 64.
[Abstract] [PDF]


Home page
J Child NeurolHome page
B.S. Russman, S.T. Iannacone, C.R. Buncher, F.J. Samaha, M. White, B. Perkins, L. Zimmerman, C. Smith, K. Burhans, and L. Barker
Spinal Muscular Atrophy: New Thoughts on the Pathogenesis and Classification Schema
J Child Neurol, October 1, 1992; 7(4): 347 - 353.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. M. Hoffman, J. C. Mazziotta, T. C. Hawk, and R. Sumida
Cerebral Glucose Utilization in Motor Neuron Disease
Arch Neurol, August 1, 1992; 49(8): 849 - 854.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. J. Halperin, G. P. Kaplan, S. Brazinsky, T. F. Tsai, T. Cheng, A. Ironside, P. Wu, J. Delfiner, M. Golightly, R. H. Brown, et al.
Immunologic Reactivity Against Borrelia burgdorferi in Patients With Motor Neuron Disease
Arch Neurol, May 1, 1990; 47(5): 586 - 594.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
J.E. Lizardi, L. I. Wolfson, and R. H. Whipple
Review Article: Neurological Dysfunction in the Elderly Prone to Fall
Neurorehabil Neural Repair, January 1, 1989; 3(3): 113 - 116.
[Abstract] [PDF]